Since 1983 percutaneous balloon dilatation of the right ventricular outflow tract has been performed as an alternative to surgical palliation in selected cases of tetralogy of Fallot at the Royal Liverpool Children's Hospital. From 31 December 1984 to 31 December 1988, 27 of these patients underwent subsequent surgical correction. Age at operation ranged from 7 to 58 months (median 2-7 years). The mean interval between balloon dilatation and correction was 15-6 months (range 3-39 months). Two patients had a systemic pulmonary shunt operation performed before dilatation and a further five required one afterwards. Overall 20 (74%) patients had some anatomical alteration as the result of balloon dilatation, while in seven (26%) there was no discernible change in the right ventricular outflow tract. There was no consistent relation between the ratio of balloon size to pulmonary annulus diameter and the morphological findings.
Since percutaneous pulmonary balloon dilatation was introduced in 1953,' it has become the treatment of choice for pulmonary valve stenosis in many centres. As suggested initially by Semb et al2 and Kan et al,3 the haemodynamic results compare favourably with those of surgery, especially when dysplastic valves are excluded. Because of this, few patients come to operation and the numerous published series' contain little information on the morphological effects of dilatation of the right ventricular outflow tract.5 7 8 In our hospital, percutaneous pulmonary balloon dilatation has been practised as an alternative to or in combination with surgical palliation in selected patients with tetralogy of Fallot.9 Because most of these patients will eventually undergo operation we were presented with an opportunity to observe the anatomical consequences of dilatation of the right ventricular outflow. The median age of the patients at operation was 33 months (range 7-58 months). Twenty one of them had one pulmonary dilatation, four had two procedures, and two patients had three and four balloon dilatations. The mean age at the first dilatation was 10-0 months (range 0-5-30); for all dilatations the median age was 14-6 months (range 0-5-56). Balloon sizes ranged from 5 to 15 mm (mean 13 mm). Surgical correction was undertaken 3 to 39 months (mean 15 6 months) after dilatation.
At operation the surgeon classified the pulmonary valve leaflets as follows: (a) intact, when there was no observable effect of dilatation; (b) detached, when the leaflet was separated from its hinge-point for a variable length, starting from one of the commissures; (c) split, when a vertical tear was found, usually in mid-portion of the leaflet dividing it in two segments (in no case was a split identified at a commissure); (d) fused, when the leaflets were fused to the pulmonary artery wall, probably after initial detachment.
The pulmonary ventriculo-arterial junction (pulmonary annulus) was described as: (a) intact, where there was no observable effect of dilatation; or (b) split, when there was a tear usually originating at the hinge-point of the leaflet and extending a variable distance into the main pulmonary artery and its right branch.
The computerised records of all the other patients (1 13) confidence intervals for all percentages.
Results Table 1 shows the findings at operation. Figure  1 is an example of a split leaflet. Overall 20 of the patients (74%) (70% CI 63%-83%) had gross evidence of damage caused by balloon dilatation. Seven patients (26%) (70% CI 17%-37%) had an intact outflow. Only five (19%) (70% CI 11%-29%) had evidence of changes that extended to more than one morphological category. No valve was found to have been split along a commissure and most valves described as "intact" were still obstructive with fused commissures. In five (19%) (70% CI 11%-29%) there was a posterior split of the pulmonary arterial wall (fig 2) , starting at the ventriculo-arterial junction and often extending into the right branch. In one of the patients who died, gross and microscopical examination showed extensive disruption of the tissues (fig 3) . The endothelial continuity was lost posteriorly at the depressed and uneven area that corresponded with the macroscopic tear, although the adventitia remained intact. Subendocardial fibrosis and elastosis were conspicuous in all sections of the adjacent right ventricular outflow septum in this patient. Table 2 shows the relation between the ratio of the balloon size to the angiographic diameter of the pulmonary annulus and the frequency of Balloon-pulmoary artery ratio ('1.) morphological change. Simple logistic regression analysis showed no relation between these two variables. None the less, there tended to be less damage with smaller balloon ratios (fig 4) . The largest group with intact valves (n = 3) had balloon/annulus ratios of < 120%.
Eighteen patients (67%) (70% CI, 56%-77%) required a transannular patch at the time of correction; and two (one after a limited transannular patch because of coronary artery anomalies) had an extracardiac conduit. There were three operative deaths. Two patients with classic tetralogy of Fallot died of low cardiac output, one of them with myocardial infarction resulting from a coronary artery injury. The third patient who died had Down's syndrome, tetralogy of Fallot, and a complete atrioventricular septal defect. He developed raised pulmonary vascular resistance and congestive heart failure after balloon dilatation of a stenosed Blalock shunt and the right ventricular outflow. The right ventricle proved inadequate to sustain the circulation postoperatively. Figures 2 and 3 show the heart from this patient.
Forty one (36%) of the 113 patients in the "control" group who did not have balloon dilatation (70% CI 31%-42%) had had a systemic pulmonary anastomosis before correction. A total of 26 (63%) patients had one palliative operation, 14 (34%) had two, and one (2%) had three operations. Shunt operations were thus significantly more common in the non-dilatation group (X2 = 3 12, p = 0-08), and fewer patients had surgical palliation when balloon dilatation had been performed. A Ring showed that balloon inflation severely damaged the right ventricular outflow tract in newborn lambs particularly when the balloon diameter was > 50% bigger than the pulmonary artery diameter.'0 In animals killed 83 and 111 days after dilatation the damaged area was occupied by small patches of fibrosis. We did not find distinctive signs of this type of trauma in our patients at operation but in most patients with tetralogy of Fallot the endocardium in areas of turbulence is usually whitened and fibrotic. We have not examined enough patients to know whether fibrosis along the right ventricular outflow (which cannot be solely attributed to the dilatation scar) will predispose to ventricular arrhythmias-as was suggested by Ring'0 commenting on the clinicopathological study by Deanfield and colleagues." By using simple logistic regression analysis, we were unable to show any significant relation between the size of the balloon and occurrence of morphological changes (table 2) , except for the general trend shown in fig 3. However, in one four month old patient, who has not yet come for correction (and therefore is not inqcluded in this report) sudden and severe hypotension and hypoxia after balloon dilatation required urgent systemicpulmonary artery anastomosis. After the chest was opened, blood was evacuated from a tense pericardium and we found disruption of the anterior right ventricular outflow tract with a large subadventitial haematoma extending across the annulus into the left pulmonary artery. Follow up catheterisation showed a small, round diverticulum protruding from the anterior aspect of the right ventricular outflow tract, confirming an extensive structural deformity.
The major changes in our series were confined to the valve leaflets; 20 (74%) of patients (70% CI, 63%-83%) had one or more of the changes described, while 22 (81%) (70% CI, 71%-89%) were free of annular/pulmonary artery disruption. The frequency of the three categories of cusp alterations was very similar (table 1) . It is striking that most of the morphological changes were found on the posterior leaflet and the posterior wall of the pulmonary trunk. We have not found an obvious explanation for this; but suggest that because this area has direct attachments to supporting structures, it would be less likely to distend under the balloon pressure and therefore would be more likely to tear or split. The anterior aspect probably is more elastic and compliant and would therefore stretch under pressure. Lock et al found multiple intimal tears in the lesions of lambs killed < 3 days after dilatation of experimentally created branch pulmonary artery strictures.'2 In some cases, these extended through all the arterial layers except the adventitia. In lambs killed 7 days after the procedure, all the tears were healed and the intima and media were intact; but the area of the old medial haemorrhage continued to show separation offibres, with the blood replaced by smooth muscle cells. In view of the interval between dilatation and operation in our patients, we expected to find an avascular, fibrous area posteriorly at the site of previous intimal disruption. The long term importance, if any, of this alteration in the pulmonary outflow is uncertain.
The pattern of use of transannular patches was similar in patients who had operations for tetralogy of Fallot at our hospital during the same period as the group who had had balloon dilatation. Judged on the need for a transannular patch, we did not find that balloon dilatation resulted in appreciable growth of the pulmonary annulus. But because our study group contained few patients with angiograms both before and after dilatation we cannot be certain. It was also our impression that it was more difficult to achieve a competent pulmonary valve mechanism after balloon dilatation. Though the posterior cusp may be used to appose an anterior monocusp patch or some valve function can be achieved through a "two cusp plasty" technique," this was often thwarted by disruption of the posterior cusp. When we analysed the incidence of a systemic to pulmonary shunt in both groups, we included only patients in whom shunting was necessary after attempted palliation by balloon dilatation. Over a third (36%) (70% CI, 31%-42%) of the control patients had one or more shunt operations performed before correction compared with 19% (70% CI, ll%-29%) in the study group which could be interpreted as showing that in 81% of patients (70% CI, 71%-89%, n = 22) a shunt was avoided, because satisfactory palliation was achieved by balloon dilatation. But the two groups were not strictly comparable in their underlying morphology, symptoms, or indications for palliation. A more rigorous, prospective randomised trial is necessary to compare accurately the role of percutaneous pulmonary balloon dilatation with surgical palliation for Fallot's tetralogy.
Given the present surgical thrust towards conservation of right ventricular and pulmonary valvar function, by means of a transatrial repair in tetralogy of Fallot,"4 it is possible that palliation also should be directed towards conservation of the pulmonary valve mechanism. The long term effects of cusp damage in patients who did not require a transannular patch remain to be determined. However, accumulating evidence suggests that continuing pulmonary regurgitation may be detrimental to right ventricular function. We found that balloon dilatation tended to split the posterior pulmonary valve leaflet or detach it from the hinge point, with or without a dehiscence in the posterior wall of the pulmonary artery. This may obviate the need for a systemic-pulmonary shunt, possibly at the expense of some anatomical damage and loss of valvar function at later correction. In view of these findings, we advise that the balloon size should be limited to 120%-140% of the diameter of the pulmonary annulus. From our present data, we cannot tell whether dilatation has any effect on the growth of the pulmonary arteries,"5 but the procedure did not seem to alter the need for a transannular patch at the time of intracardiac repair.
